INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
104 hedge funds and large institutions have $633M invested in Infinity Pharmaceuticals, Inc. in 2013 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 34 increasing their positions, 33 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
24% less capital invested
Capital invested by funds: $835M → $633M (-$202M)
Holders
104
Holding in Top 10
2
Calls
$13.7M
Puts
$13.9M
Top Buyers
| 1 | +$25M | |
| 2 | +$18.6M | |
| 3 | +$13.1M | |
| 4 |
BC
Broadfin Capital
New York
|
+$9.75M |
| 5 |
Renaissance Technologies
New York
|
+$7.68M |
Top Sellers
| 1 | -$37.6M | |
| 2 | -$35.4M | |
| 3 | -$10.2M | |
| 4 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$8.87M |
| 5 |
QF
QVT Financial
New York
|
-$8.36M |